OPEN END TURBO OPTIONSSCHEIN LONG - BECTON DICKINSON AND CO. Share Price

Certificat

DE000GK9PNT1

Real-time BOERSE MUENCHEN 19:27:15 18/06/2024 BST
17.57 EUR 0.00% Intraday chart for OPEN END TURBO OPTIONSSCHEIN LONG - BECTON DICKINSON AND CO.
Current month+2.99%
1 month+0.11%
Date Price Change
18/06/24 17.57 0.00%
17/06/24 17.57 -0.23%
14/06/24 17.61 +1.27%
13/06/24 17.39 -0.80%
12/06/24 17.53 -1.90%

Real-time BOERSE MUENCHEN

Last update June 18, 2024 at 07:27 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Goldman Sachs
WKN GK9PNT
ISINDE000GK9PNT1
Date issued 26/08/2022
Strike 44.8 $
Maturity Unlimited
Parity 10 : 1
Emission price 21.72
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 22.04
Lowest since issue 16.48
Spread 0.02
Spread %0.11%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
232.8 USD
Average target price
279.2 USD
Spread / Average Target
+19.95%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW